Pathway Enrichment Analysis in R: Tools and Visualization for Omics Interpretation

Pathway enrichment analysis is a core computational step in omics research that translates long lists of differentially expressed genes or proteins into interpretable biological themes. This article explains the two main enrichment approaches, over-representation analysis and functional class scoring, and shows how to implement them in R using clusterProfiler, enrichplot, and pathview. You will learn how to prepare input data, run enrichment tests, interpret dot plots and enrichment maps, and avoid common errors that produce misleading biological conclusions.

What Pathway Enrichment Analysis Does

High-throughput experiments routinely produce lists of hundreds or thousands of genes that change between conditions. Reading such lists gene by gene does not reveal the underlying biology. Pathway enrichment analysis addresses this by asking whether genes from known biological pathways appear in your results more often than expected by chance. The output is a ranked set of pathways, each with a statistical score, that you can use to generate hypotheses about mechanisms, select candidates for validation, or compare your findings with published studies.

The method rests on curated databases that organize genes into functional units. The Kyoto Encyclopedia of Genes and Genomes (KEGG) provides pathway maps for metabolism, signaling, and disease processes. Gene Ontology (GO) classifies genes by biological process, molecular function, and cellular component. Both are common targets for enrichment testing in R. The EMBL-EBI Training portal offers structured materials on functional annotation and interpretation of omics data, and the NCBI Data Resources provide access to gene identifiers and annotation files that you will need for mapping your results.

Over-Representation Analysis and Functional Class Scoring

Two statistical frameworks dominate enrichment testing. Each answers a different question and has distinct data requirements.

Over-Representation Analysis

Over-representation analysis (ORA) takes a list of genes that passed your significance threshold, for example adjusted p-value below 0.05, and tests whether any curated pathway contains more of those genes than expected by chance. The test uses a hypergeometric distribution or an equivalent Fisher exact test. The inputs are the list of significant genes, the total number of genes measured in your experiment, and the pathway annotations.

ORA is simple to run and interpret. It works with any organism that has pathway annotations. The main limitation is that it discards information about effect size and expression magnitude. A gene with a small but consistent change counts the same as a gene with a massive fold change. ORA also depends heavily on where you set your significance threshold, and changing that cutoff can change which pathways appear enriched.

Functional Class Scoring

Functional class scoring (FCS) methods, including gene set enrichment analysis (GSEA), use the full ranked list of genes instead of a thresholded subset. Every gene contributes its test statistic, such as a t-statistic or fold change, to the pathway score. The method asks whether genes in a pathway tend to cluster at the top or bottom of the ranked list.

FCS is more sensitive than ORA for detecting coordinated but modest expression changes across a pathway. It does not require you to choose a significance cutoff for individual genes. The tradeoff is greater computational complexity and more assumptions about how the gene-level statistics are distributed. You also need complete ranking information for all measured genes, beyond the significant subset.

R Packages for Enrichment Analysis

The R ecosystem contains several mature packages for enrichment testing. The choice depends on your data type, organism, and preferred output format.

clusterProfiler

clusterProfiler is the most widely used package for enrichment analysis in R. It supports ORA and GSEA for GO, KEGG, and many other annotation sources. The package handles the conversion of gene identifiers, performs the statistical tests, and produces objects that feed directly into visualization functions. Published studies across diverse fields use clusterProfiler for GO and KEGG enrichment. A study of the Shenfu Qiangxin Pill for heart failure used clusterProfiler to identify pathways related to ventricular remodeling and calcium signaling from network pharmacology data [5]. A multi-omics analysis of stomach adenocarcinoma used clusterProfiler for pathway enrichment to characterize prognostic gene signatures and immune infiltration patterns [7]. A bibliometric analysis of RNA m5C modification in cancer used clusterProfiler and enrichplot to visualize GO and KEGG enrichment results [8].

The package accepts a vector of gene identifiers or a ranked vector for GSEA. It returns a data frame with enrichment scores, adjusted p-values, and gene counts for each pathway. The output object stores the full details needed for plotting.

enrichplot

enrichplot provides the visualization layer for clusterProfiler results. It generates dot plots, bar plots, enrichment maps, and network diagrams directly from enrichment result objects. The package handles the layout and color mapping so you can inspect patterns without writing custom plotting code. Common outputs include dot plots that show gene count and adjusted p-value for each pathway, and enrichment maps that connect pathways sharing genes.

pathview

pathview draws expression data onto KEGG pathway diagrams. It takes a list of genes with their expression values and a KEGG pathway identifier, then produces a colored pathway image showing which genes are up or down regulated. This is useful for examining the specific genes driving an enrichment signal. The package downloads pathway images from KEGG and maps your data onto the nodes.

Additional Packages

Other packages address specific enrichment scenarios. KeyPathwayMineR performs de novo pathway enrichment in the R ecosystem, which means it identifies active pathways from expression data without relying on predefined gene sets [16]. NEArender provides network enrichment analysis for functional interpretation of omics data, using network topology to score pathway activity [17]. These tools are useful when standard curated annotations are incomplete or when you want to incorporate interaction structure into the analysis.

At a Glance: Package Comparison

Preparing Input Data

The quality of enrichment results depends on the quality of your input data. Spend time on identifier consistency and annotation completeness before running any test.

Gene Identifier Format

R packages expect gene identifiers in a specific format. Common options include Entrez Gene IDs, Ensembl IDs, and official gene symbols. clusterProfiler can convert between formats using annotation packages, but the conversion is only as good as the underlying mapping. Check that your identifiers match the reference organism. Human, mouse, and rat have different annotation packages, and mixing them produces empty results or false enrichments.

The NCBI Data Resources provide authoritative gene identifier information and annotation files. Use these to verify that your identifiers are current and correctly mapped to the intended organism.

Background Gene Set

ORA requires a background set that represents all genes you could have detected in your experiment. For RNA-seq data, this is typically all genes with non-zero counts across samples. For microarray data, it is all genes represented on the array. Using the wrong background, such as all genes in the genome instead of all detected genes, inflates significance because the test assumes you had the opportunity to detect every gene in the background.

Ranked Lists for GSEA

For GSEA, you need a ranked list of all measured genes. The ranking metric is usually a signed statistic such as log2 fold change or a t-statistic. The sign matters because it indicates direction of change. Genes with positive values are up regulated and genes with negative values are down regulated. The ranking should include all genes, beyond significant ones, because the method uses the full distribution.

Running Enrichment Analysis with clusterProfiler

The workflow below shows a typical clusterProfiler session for ORA and GSEA. The code assumes you have a vector of significant gene identifiers and a separate ranked vector for GSEA.

Over-Representation Analysis Workflow

Start by loading the required packages and your gene list. The gene list should contain unique identifiers in the format expected by the annotation package.

library(clusterProfiler)
library(org.Hs.eg.db)

## significant_genes is a character vector of Entrez IDs
## background_genes is a character vector of all detected Entrez IDs

ego <- enrichGO(
  gene = significant_genes,
  universe = background_genes,
  OrgDb = org.Hs.eg.db,
  ont = "BP",
  pAdjustMethod = "BH",
  pvalueCutoff = 0.05,
  qvalueCutoff = 0.2,
  readable = TRUE
)

The enrichGO function tests enrichment against Gene Ontology biological process terms. The universe argument sets the background. The pAdjustMethod controls multiple testing correction, with Benjamini-Hochberg being the standard choice. The readable argument converts Entrez IDs to gene symbols in the output.

For KEGG enrichment, use enrichKEGG with the organism code. Human is hsa, mouse is mmu, and rat is rno.

ekegg <- enrichKEGG(
  gene = significant_genes,
  organism = "hsa",
  pvalueCutoff = 0.05,
  qvalueCutoff = 0.2
)

Gene Set Enrichment Analysis Workflow

GSEA requires a named ranked vector where the names are gene identifiers and the values are the ranking statistics.

## ranked_genes is a named numeric vector
## names are Entrez IDs, values are signed test statistics

gsea_result <- gseKEGG(
  geneList = ranked_genes,
  organism = "hsa",
  pvalueCutoff = 0.05,
  verbose = FALSE
)

The gseKEGG function runs GSEA against KEGG pathways. The geneList must be sorted in decreasing order of the ranking statistic. clusterProfiler handles the sorting internally, but you should verify that the vector contains no missing values and no duplicate names.

Visualizing Enrichment Results

Visualization turns enrichment tables into interpretable figures. The choice of plot depends on the question you want to answer.

Dot Plots

Dot plots are the standard summary view for enrichment results. Each dot represents one pathway. The x-axis shows the gene ratio, which is the proportion of significant genes in the pathway relative to the total significant genes. The y-axis lists the pathway names. Dot size reflects the number of genes in the pathway, and dot color shows the adjusted p-value.

library(enrichplot)

dotplot(ego, showCategory = 20)

The showCategory argument controls how many pathways appear. Twenty is a reasonable default for a summary figure. Larger numbers produce crowded plots that are hard to read.

Enrichment Maps

Enrichment maps show relationships between pathways. Pathways that share many genes are connected by edges, and the network layout reveals clusters of related biological processes. This is useful when your results contain many overlapping GO terms that differ only slightly in gene composition.

emapplot(pairwise_termsim(ego), showCategory = 30)

The pairwise_termsim function computes gene overlap between pathways before plotting. The resulting map groups related pathways into clusters, which helps you identify the dominant biological themes in your data.

Pathway Diagrams

Pathview draws expression values onto KEGG pathway diagrams. This shows exactly which genes in a pathway are changing and in which direction.

library(pathview)

## log2_fold_changes is a named numeric vector
## names are Entrez IDs, values are log2 fold changes

pathview(
  gene.data = log2_fold_changes,
  pathway.id = "hsa04020",
  species = "hsa",
  out.suffix = "example"
)

The output is a PNG image of the KEGG pathway with genes colored by expression change. Red indicates up regulation and green indicates down regulation in the default settings. The pathway.id must match a valid KEGG pathway identifier for your organism.

Interpreting Enrichment Results

Statistical significance does not equal biological importance. A pathway can be enriched because of a few highly influential genes or because of broad coordinated changes. Interpret your results with attention to effect size, gene overlap, and biological plausibility.

Gene Ratio and Count

The gene ratio tells you what fraction of your significant genes fall in a given pathway. A high ratio with a small count means the pathway contains few genes but most are significant. A low ratio with a large count means the pathway contains many genes but only a fraction are significant. Both patterns can be biologically meaningful, but they suggest different mechanisms.

Adjusted P-Values

The adjusted p-value accounts for multiple testing across all pathways in the database. Use it as the primary filter for reporting. The q-value is a related measure that estimates the false discovery rate. clusterProfiler reports both, and you should state which one you used in your methods.

Overlapping Pathways

Many pathways share genes, especially in GO where terms are organized hierarchically. A parent term and its child term may both appear enriched because they contain the same significant genes. This is not an error, but it means you should not treat each pathway as an independent finding. Enrichment maps help you see these overlaps and identify the most specific terms that capture the signal.

Common Failure Patterns

Several recurring problems produce misleading enrichment results. Recognizing them early saves time and prevents incorrect conclusions.

Identifier Mismatch

The most common failure is using identifiers that do not match the annotation package. Gene symbols are particularly problematic because they change over time and can be ambiguous across organisms. Entrez IDs are more stable but less readable. Always verify that your identifiers map to the expected organism and that the mapping produces a reasonable number of annotated genes.

Wrong Background

Using the whole genome as background when your experiment only detected a subset of genes inflates significance. The enrichment test compares your significant genes against the background, and a background that includes undetectable genes makes your observed counts look more extreme than they are. Use the set of genes that passed your expression filter as the background.

Unsorted or Duplicated Ranked Lists

GSEA requires a ranked list with unique names and no missing values. Duplicated gene names cause errors or silent misbehavior. Missing values are dropped, which changes the ranking. Sort the list in decreasing order and check for duplicates before running the analysis.

Overinterpreting Small Gene Sets

Pathways with very few genes can show extreme enrichment ratios based on one or two genes. A pathway with three genes where two are significant looks impressive but may not represent a coordinated biological response. Check the gene count and examine the individual genes before drawing conclusions.

Reproducibility and Reporting

Enrichment analysis is only useful if others can reproduce your results. Document every parameter and version.

Session Information

Record the R version, package versions, and annotation database versions. The sessionInfo function captures this information. Package updates can change annotation content and statistical results, so version control matters.

Parameter Documentation

Report the significance thresholds, multiple testing correction method, background gene set, and ranking metric. These choices affect the results and should be stated explicitly in your methods section.

Data Availability

Deposit your input data and code in a public repository. The NIH Genomic Data Sharing Policy describes expectations for sharing genomic data generated with NIH funding. Following the FAIR Guiding Principles for findable, accessible, interoperable, and reusable data improves the value of your work for the broader community.

Limitations of Enrichment Analysis

Enrichment analysis has inherent limitations that no software package can overcome.

Annotation Completeness

Pathway databases are incomplete. Many genes have no pathway annotation, and many pathways are only partially characterized. This is especially true for non-model organisms. A study on enhanced RNA-seq expression profiling in non-model organisms using custom annotations highlights the need for tailored annotation resources when standard databases are insufficient [6]. If your organism lacks good annotations, enrichment results will underrepresent the true biology.

Gene Set Composition

Curated gene sets reflect current knowledge, which changes over time. A pathway definition from an older database version may differ from the current version. This affects comparability across studies and explains why reanalysis with updated annotations can change results.

Statistical Assumptions

ORA assumes genes are independent, which is not true for genes in the same pathway that are co-regulated. FCS methods relax this assumption but introduce their own requirements about the distribution of gene-level statistics. Both approaches can produce false positives when assumptions are violated.

Quality Control Checks

Run these checks before accepting enrichment results.

Verify Input Integrity

Confirm that your gene list contains no duplicates, no missing values, and no identifiers that fail to map to the annotation package. The proportion of unmapped genes should be small. A high unmapped rate indicates an identifier format problem.

Check Background Coverage

The background gene set should cover most of the genes in your annotation database. If the background is much smaller than expected, you may have filtered too aggressively or used the wrong identifier format.

Examine Top Pathways

Read the actual genes in your top enriched pathways. Do they make biological sense given your experimental context? If the top pathway is unrelated to your system, check for identifier errors or background problems.

Compare Methods

Run both ORA and GSEA on the same data. Pathways that appear in both analyses are more robust than those appearing in only one. Discrepancies can reveal threshold effects or ranking issues.

Professional Escalation Criteria

Some situations require consultation with a bioinformatics specialist or statistician.

Persistent Identifier Problems

If a large fraction of your genes fail to map to annotations despite correct formatting, you may need custom annotation resources. This is common for non-model organisms and requires specialized approaches [6].

Conflicting Results Across Methods

When ORA and GSEA give very different answers, the cause may be subtle issues in data processing or statistical assumptions. A specialist can help diagnose whether the discrepancy reflects real biology or technical artifacts.

Complex Experimental Designs

Enrichment analysis assumes simple group comparisons. Designs with batch effects, covariates, or repeated measures require more sophisticated approaches that account for these factors before enrichment testing.

Regulatory or Clinical Implications

If your enrichment results will inform clinical decisions or regulatory submissions, involve a statistician early. The analysis must meet higher standards of rigor and documentation than exploratory research.

Frequently Asked Questions

What is the difference between ORA and GSEA?

Over-representation analysis tests whether a predefined list of significant genes contains more genes from a pathway than expected by chance. Gene set enrichment analysis uses the full ranked list of all measured genes and detects coordinated shifts in expression across a pathway without requiring a significance threshold for individual genes. ORA is simpler and works with small gene lists. GSEA is more sensitive for detecting modest but consistent changes.

Which R package should I use for pathway enrichment?

clusterProfiler is the most widely used and best documented option for standard GO and KEGG enrichment. It supports both ORA and GSEA and produces objects that work with the enrichplot visualization package. For specialized needs, KeyPathwayMineR offers de novo pathway enrichment [16] and NEArender provides network-based enrichment analysis [17].

How do I choose the background gene set?

The background should include all genes you could have detected in your experiment. For RNA-seq, use all genes with non-zero counts. For microarrays, use all genes on the array. Using the whole genome as background when your experiment detected fewer genes inflates significance and produces false positives.

What does the gene ratio mean in a dot plot?

The gene ratio is the number of significant genes in a pathway divided by the total number of significant genes in your input list. It shows what fraction of your significant results fall in each pathway. A high gene ratio with a small gene count means the pathway contains few genes but most are significant.

How do I handle overlapping pathways in my results?

Overlapping pathways share genes and are not independent findings. Use an enrichment map to visualize the overlap structure and identify clusters of related pathways. Report the most specific terms that capture the signal instead of listing every overlapping term as a separate finding.

Why did my enrichment analysis return no significant pathways?

Check your input identifiers, background gene set, and significance thresholds. Identifier mismatches are the most common cause of empty results. Verify that your gene list maps to the annotation package and that the background contains a reasonable number of genes.

Can I use enrichment analysis for non-model organisms?

Yes, but standard annotation databases may be incomplete. Custom annotations can improve results for non-model organisms [6]. You may need to build your own gene set definitions or use de novo approaches like KeyPathwayMineR [16] when curated annotations are insufficient.

How should I report enrichment results in my publication?

Report the package versions, annotation database versions, significance thresholds, multiple testing correction method, background gene set, and ranking metric. Provide the full enrichment table as supplementary data and deposit code and input data in a public repository following the FAIR Guiding Principles.

Related Bioinformatics Guides

• Gene Ontology (GO) and Enrichment Analysis
• The KEGG Database and Pathway Analysis
• Epigenetics and Computational DNA Methylation Analysis: Mechanisms, Methods, and Veterinary Applications
• The Reactome Pathway Knowledgebase
• MicroRNA Target Prediction Tools

References and Further Reading

• EMBL-EBI Training. European Bioinformatics Institute.
• NCBI Data Resources. National Center for Biotechnology Information.
• Genomic Data Sharing Policy. National Institutes of Health.
• The FAIR Guiding Principles. Scientific Data.
• Analysis of Chemical Constituents and Anti-Heart Failure Mechanism of Shenfu Qiangxin Pill by UHPLC-Q-Orbitrap HRMS Combined with Network Pharmacology. 2026.
• Enhanced RNA-Seq Expression Profiling and Functional Enrichment in Non-model Organisms Using Custom Annotations. 2026.
• Based on comprehensive analysis of ScRNA-seq and bulk RNA-seq, identification of palmitoylation-related genes as biomarkers to evaluate prognosis and immune landscape in stomach adenocarcinoma.. 2026.
• Global research trends on the relationship between RNA m5C modification and cancer progression: a comprehensive visualization and bibliometric analysis (1900-2024). Biophysics Reports, 2026.
• Do LLMs Have Visualization Literacy? An Evaluation on Modified Visualizations to Test Generalization in Data Interpretation. IEEE Transactions on Visualization and Computer Graphics, 2025.
• An Empirical Evaluation of the GPT-4 Multimodal Language Model on Visualization Literacy Tasks. IEEE Transactions on Visualization and Computer Graphics, 2024.
• VisEval: A Benchmark for Data Visualization in the Era of Large Language Models. IEEE Transactions on Visualization and Computer Graphics, 2024.
• Are LLMs ready for Visualization?. IEEE Pacific Visualization Symposium, 2024.
• Design Patterns for Situated Visualization in Augmented Reality. IEEE Transactions on Visualization and Computer Graphics, 2023.
• Affective Visualization Design: Leveraging the Emotional Impact of Data. IEEE Transactions on Visualization and Computer Graphics, 2023.
• Challenges and Opportunities in Data Visualization Education: A Call to Action. IEEE Transactions on Visualization and Computer Graphics, 2023.
• KeyPathwayMineR: De Novo Pathway Enrichment in the R Ecosystem. Frontiers in Genetics, 2022.
• NEArender: An R package for functional interpretation of 'omics' data via network enrichment analysis. BMC Bioinformatics, 2017.

This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.